Countries SEA Countries
The Phase 3 clinical trial, which is planned to commence later in 2023, is a multi-center, multi-country study designed to evaluate the safety and immunoge...
June 02, 2023 | News
87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...
June 01, 2023 | News
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic coope...
May 16, 2023 | News
–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...
May 01, 2023 | News
Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...
April 26, 2023 | News
“Historically, we have seen a dual strategy of focusing on China and the US for emerging innovators in China. However, a series of recent setbacks wi...
April 13, 2023 | News
Digital Health Funding in Massachusetts Continues to Thrive Led by Investment in Key Therapeutic Areas Galen Growth, the...
April 12, 2023 | News
The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...
April 12, 2023 | News
At the same time, it is crucial to understand that the implementation of AI and ML technologies requires eradicative change within the whole company struct...
March 31, 2023 | News
Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and qualit...
March 31, 2023 | News
Singapore: A Biopharma Hub Singapore is one of the most prominent players in the Southeast Asian biopharma industry. It has positioned itself as a hub for...
March 31, 2023 | News
Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. Junshi Biosciences has conducted over 30 clinical tr...
March 31, 2023 | News
Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...
March 29, 2023 | Influencers
Survey of 7,000+ people in Asia shows expectation of early retirement, early deterioration in health Concerns about cost of well-being nu...
March 29, 2023 | News
Most Read
Bio Jobs
News